NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer
30th May 2022 Uncategorised 0The injection is given in combination with chemotherapy and administered once every three weeks More: NICE approves Merck’s Keytruda for adult patients with rare triple negative breast cancer Source: News
read more